PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-11-07

Date Title Company
07-Nov-2022 Medvantx Launches Fully Integrated Pharmacy Platform and Appoints Key Executives to Advance Access to Healthcare Businesswire
07-Nov-2022 Rallybio Reports Third Quarter 2022 Financial Results Businesswire
07-Nov-2022 Astria Therapeutics to Present STAR-0215 Modeling and Simulation Data at the 2022 American College of Allergy, Asthma and Immunology Annual Meeting Businesswire
07-Nov-2022 Sesen Bio Reports Third Quarter 2022 Financial Results and Business Update Businesswire
07-Nov-2022 Wugen to Present Data Characterizing WU-NK-101 at The Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting Businesswire
07-Nov-2022 Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients Businesswire
07-Nov-2022 Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer Businesswire
07-Nov-2022 Protein Expression Global Market Report 2022: Escalating Demand for Biologics Driving Growth - ResearchAndMarkets.com Businesswire
07-Nov-2022 Bicara Therapeutics Presents Preclinical Data for Precision Immunocytokine, BCA356, at Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting Businesswire
07-Nov-2022 OliX Pharmaceuticals Announces Positive Preclinical Data in NASH Non-human Primate Models Businesswire
07-Nov-2022 Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting Businesswire
07-Nov-2022 LevitasBio Completes Series C Financing Businesswire
07-Nov-2022 Global Crohn's Disease Therapeutics Market to 2027 - Adoption of Biologic Therapies is Driving Growth - ResearchAndMarkets.com Businesswire
07-Nov-2022 Global RNA Analysis Market Report 2022: Single Cell Transcriptomics And Associated Big Data Presents Opportunities - ResearchAndMarkets.com Businesswire
07-Nov-2022 Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 Businesswire
07-Nov-2022 ADC Therapeutics to Participate in the Jefferies London Healthcare Conference Businesswire
07-Nov-2022 Global Primary Cells Market Report 2022: Growing Demand for HLA-Typed Human Primary Cells Presents Opportunities - ResearchAndMarkets.com Businesswire
07-Nov-2022 bluebird bio Reports Third Quarter 2022 Financial Results and Highlights Operational Progress Businesswire
07-Nov-2022 Glaukos Announces Participation in the Stephens Annual Investment Conference Businesswire
07-Nov-2022 New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference Gendius